The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Epinephrine Injection-Global Market Insights and Sales Trends 2024
Synopsis
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
The global Epinephrine Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Epinephrine Injection in various end use industries. The expanding demands from the Anaphylaxis, Cardiac Arrest and Others,, are propelling Epinephrine Injection market. Epinephrine Auto-injector, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Epinephrine Prefilled Syringe segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Epinephrine Injection market, driven by demand from China, the second largest economy with some signs of stabilising, the Epinephrine Injection market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Epinephrine Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Epinephrine Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Epinephrine Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Epinephrine Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Epinephrine Injection covered in this report include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma and Harvest Pharmaceuticals, etc.
The global Epinephrine Injection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Global Epinephrine Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Epinephrine Injection market, Segment by Type:
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Global Epinephrine Injection market, by Application
Anaphylaxis
Cardiac Arrest
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Epinephrine Injection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
The global Epinephrine Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Epinephrine Injection in various end use industries. The expanding demands from the Anaphylaxis, Cardiac Arrest and Others,, are propelling Epinephrine Injection market. Epinephrine Auto-injector, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Epinephrine Prefilled Syringe segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Epinephrine Injection market, driven by demand from China, the second largest economy with some signs of stabilising, the Epinephrine Injection market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Epinephrine Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Epinephrine Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Epinephrine Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Epinephrine Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Epinephrine Injection covered in this report include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma and Harvest Pharmaceuticals, etc.
The global Epinephrine Injection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Global Epinephrine Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Epinephrine Injection market, Segment by Type:
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Global Epinephrine Injection market, by Application
Anaphylaxis
Cardiac Arrest
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Epinephrine Injection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Epinephrine Injection
1.1 Epinephrine Injection Market Overview
1.1.1 Epinephrine Injection Product Scope
1.1.2 Epinephrine Injection Market Status and Outlook
1.2 Global Epinephrine Injection Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Epinephrine Injection Market Size by Region (2018-2029)
1.4 Global Epinephrine Injection Historic Market Size by Region (2018-2023)
1.5 Global Epinephrine Injection Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Epinephrine Injection Market Size (2018-2029)
1.6.1 North America Epinephrine Injection Market Size (2018-2029)
1.6.2 Europe Epinephrine Injection Market Size (2018-2029)
1.6.3 Asia-Pacific Epinephrine Injection Market Size (2018-2029)
1.6.4 Latin America Epinephrine Injection Market Size (2018-2029)
1.6.5 Middle East & Africa Epinephrine Injection Market Size (2018-2029)
2 Epinephrine Injection Market by Type
2.1 Introduction
2.1.1 Epinephrine Auto-injector
2.1.2 Epinephrine Prefilled Syringe
2.1.3 Combination Epinephrine Products
2.2 Global Epinephrine Injection Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Epinephrine Injection Historic Market Size by Type (2018-2023)
2.2.2 Global Epinephrine Injection Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Epinephrine Injection Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Epinephrine Injection Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Epinephrine Injection Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Epinephrine Injection Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Epinephrine Injection Revenue Breakdown by Type (2018-2029)
3 Epinephrine Injection Market Overview by Application
3.1 Introduction
3.1.1 Anaphylaxis
3.1.2 Cardiac Arrest
3.1.3 Others
3.2 Global Epinephrine Injection Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Epinephrine Injection Historic Market Size by Application (2018-2023)
3.2.2 Global Epinephrine Injection Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Epinephrine Injection Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Epinephrine Injection Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Epinephrine Injection Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Epinephrine Injection Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Epinephrine Injection Revenue Breakdown by Application (2018-2029)
4 Epinephrine Injection Competition Analysis by Players
4.1 Global Epinephrine Injection Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Epinephrine Injection as of 2022)
4.3 Date of Key Players Enter into Epinephrine Injection Market
4.4 Global Top Players Epinephrine Injection Headquarters and Area Served
4.5 Key Players Epinephrine Injection Product Solution and Service
4.6 Competitive Status
4.6.1 Epinephrine Injection Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Mylan Inc
5.1.1 Mylan Inc Profile
5.1.2 Mylan Inc Main Business
5.1.3 Mylan Inc Epinephrine Injection Products, Services and Solutions
5.1.4 Mylan Inc Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.1.5 Mylan Inc Recent Developments
5.2 Impax
5.2.1 Impax Profile
5.2.2 Impax Main Business
5.2.3 Impax Epinephrine Injection Products, Services and Solutions
5.2.4 Impax Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.2.5 Impax Recent Developments
5.3 ALK Abello
5.3.1 ALK Abello Profile
5.3.2 ALK Abello Main Business
5.3.3 ALK Abello Epinephrine Injection Products, Services and Solutions
5.3.4 ALK Abello Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.3.5 Lincoln Medical Ltd Recent Developments
5.4 Lincoln Medical Ltd
5.4.1 Lincoln Medical Ltd Profile
5.4.2 Lincoln Medical Ltd Main Business
5.4.3 Lincoln Medical Ltd Epinephrine Injection Products, Services and Solutions
5.4.4 Lincoln Medical Ltd Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.4.5 Lincoln Medical Ltd Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Epinephrine Injection Products, Services and Solutions
5.5.4 Pfizer Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 Amphastar
5.6.1 Amphastar Profile
5.6.2 Amphastar Main Business
5.6.3 Amphastar Epinephrine Injection Products, Services and Solutions
5.6.4 Amphastar Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.6.5 Amphastar Recent Developments
5.7 Emerade
5.7.1 Emerade Profile
5.7.2 Emerade Main Business
5.7.3 Emerade Epinephrine Injection Products, Services and Solutions
5.7.4 Emerade Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.7.5 Emerade Recent Developments
5.8 Grand Pharma
5.8.1 Grand Pharma Profile
5.8.2 Grand Pharma Main Business
5.8.3 Grand Pharma Epinephrine Injection Products, Services and Solutions
5.8.4 Grand Pharma Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.8.5 Grand Pharma Recent Developments
5.9 Harvest Pharmaceuticals
5.9.1 Harvest Pharmaceuticals Profile
5.9.2 Harvest Pharmaceuticals Main Business
5.9.3 Harvest Pharmaceuticals Epinephrine Injection Products, Services and Solutions
5.9.4 Harvest Pharmaceuticals Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.9.5 Harvest Pharmaceuticals Recent Developments
5.10 Merit Pharmaceutical
5.10.1 Merit Pharmaceutical Profile
5.10.2 Merit Pharmaceutical Main Business
5.10.3 Merit Pharmaceutical Epinephrine Injection Products, Services and Solutions
5.10.4 Merit Pharmaceutical Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.10.5 Merit Pharmaceutical Recent Developments
5.11 Tianjin Jinyao Group
5.11.1 Tianjin Jinyao Group Profile
5.11.2 Tianjin Jinyao Group Main Business
5.11.3 Tianjin Jinyao Group Epinephrine Injection Products, Services and Solutions
5.11.4 Tianjin Jinyao Group Epinephrine Injection Revenue (US$ Million) & (2018-2023)
5.11.5 Tianjin Jinyao Group Recent Developments
6 North America
6.1 North America Epinephrine Injection Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Epinephrine Injection Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Epinephrine Injection Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Epinephrine Injection Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Epinephrine Injection Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Epinephrine Injection Market Dynamics
11.1 Epinephrine Injection Industry Trends
11.2 Epinephrine Injection Market Drivers
11.3 Epinephrine Injection Market Challenges
11.4 Epinephrine Injection Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
